About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Purpose:
The Investigative Toxicology and Pathology Group is searching for a highly motivated and self-driven candidate to conduct laboratory functions including histology and microscopy techniques (tissue processing, slide preparation, immunohistochemistry, in situ hybridization) and image analysis to contribute to understanding the relevance of safety findings of experimental compounds.
Responsibilities:
* Conduct laboratory tests including histology and microscopy techniques (tissue processing, slide preparation, immunohistochemistry, in situ hybridization) and image analysis.
* Participate in the design and conduct of experiments to identify and characterize toxic liabilities of lead candidates and investigate mechanisms of action: design experiments, collect samples from in vivo studies, generate protocols and relevant end points, analyze data, recommend solutions for issues.
* Partner with toxicologic pathologists, molecular toxicologists, and discovery scientists to obtain materials for analysis.
* Provide timely analysis and interpretation of data, communicate data and interpretation to project stakeholders, and help prepare reports.
* Respond quickly to information learned from ongoing experiments and provide input to project stakeholders to guide project direction and prioritization.
* Ensure proper documentation and archiving of all data generated.
* Comfortable working independently as well as part of a team with peers to achieve the assigned goals.
Qualifications
Qualifications:
* High School diploma or GED is required and at least 5-7 years prior technical experience in area(s) of specialty.
* Bachelors degree and 3-5 years prior technical experience in area(s) of specialty preferred.
* Experience with histologic processing/sectioning/staining of tissues and immunohistochemistry required.
* Skills in basic analytical, molecular biology, and biochemical procedures and cell biology tools (i.e., RT-PCR, Western blot, ELISA, in vitro cell culture techniques, transmission electron microscopy, and laser-capture microscopy) are desirable.
* Knowledge of basic regulatory requirements.
* Communication Skills Ability to concisely communicate key issues to stakeholders.
* Analytical Skills Ability to assess issues that arise, seek multiple perspectives, gather more information as needed, and identify key issues that need to be addressed.
* Computer Literacy Basic competence of spreadsheets, word processing, and email and knowledge of computerized maintenance management systems and purchasing systems.
* Planning Ability to design, plan, organize and implement tasks within an allotted timeframe.
*Job level will be commensurate with experience
Significant Work Activities
N/A
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.